Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal,hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO,CACA, DAHANCA,EORTC, GEORCC,GORTEC, HKNPCSG,HNCIG, IAG-KHT,LPRHHT, NCIC CTG,NCRI, NRG Oncology,PHNS, SBRT,SOMERA, SRO,SSHNO, TROG consensus guidelines |
| Affiliation: | 1. Université catholique de Louvain, St-Luc University Hospital, Department of Radiation Oncology, Brussels, Belgium;2. Velindre Cancer Centre, Department of Radiation Oncology, Wales, UK;3. Stanford University School of Medicine, Department of Radiation Oncology, USA;4. CHUV and University of Lausanne, Department of Radiation Oncology, Switzerland;5. Charité University Hospital, Department of Radio-oncology and Radiotherapy, Berlin, Germany;6. Sun Yat-Sen University, Cancer Centre, Department of Radiation Oncology, Guangzhou, China;g. University of Michigan Health System, Department of Radiation Oncology, Ann Arbor, USA;h. Department of Radiation Oncology, Sichuan Cancer Hospital, Chengdu, China;i. Vall d''Hebron University Hospital, Radiation Oncology Service, Barcelona, Spain;j. Tata Memorial Hospital, Department of Radiation Oncology, Mumbai, India;k. Université catholique de Louvain, St-Luc University Hospital, Department of Head and Neck Surgery, Brussels, Belgium;l. Hospital Israelita Albert Einstein, Department of Radiation Oncology, Sao Paulo, Brazil;m. Fudan University Shanghai Cancer Center, Department of Radiation Oncology, China;n. University of Sheffield, School of Clinical Dentistry, Unit of Oral and Maxillofacial Pathology, UK;o. Odense University Hospital, Department of Oncology, Denmark;p. Radboud University Medical Centre, Department of Radiation Oncology, Nijmegen, The Netherlands;q. University of Hong Kong and University of Hong Kong Shenzhen Hospital, Department of Clinical Oncology, Hong Kong, China;r. Hôpitaux Universitaires Pitié Salpêtrière – Charles Foix, Department of Radiation Oncology, Paris, France;s. University of Helsinki and Helsinki University Hospital, Department of Otorhinolaryngology – Head & Neck Surgery, Finland;t. Universita'' Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Polo Scienze Oncologiche ed Ematologiche, Rome, Italy;u. University of Brescia, Divisions of Otorhinolaryngology – Head and Neck Surgery, Italy;v. University of Toronto, The Princess Margaret Hospital, Department of Radiation Oncology, Canada;w. Medica Sur, Unit for Radiotherapy, México DF, Mexico;x. Princess Alexander Hospital, Department of Radiation Oncology, Brisbane, Australia;y. Institute of Oncology, Maria Sklodowska-Curie Cancer Center, Gliwice, Poland;z. Asklepios St. Georg Hospital, Hermann-Holthusen Institute for Radiotherapy, Hamburg, Germany;11. National Cancer Centre Singapore, Division of Radiation Oncology, Singapore;12. Case Western Reserve University Hospital, Department of Radiation Oncology, Cleveland, USA;13. University of California-San Francisco, Department of Radiation Oncology, USA;14. University Hospital Basel, Clinic of Radiotherapy and Radiation Oncology, Switzerland;15. Aarhus University Hospital, Department of Oncology, Denmark |
